Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
December 10, 2019
Patent Application Number
15353886
Date Filed
November 17, 2016
Patent Citations Received
...
Patent Primary Examiner
Patent abstract
The present invention provides molecules, such as ISVDs and Nanobodies, that bind to CTLA4 or human serum albumin. These molecules have been engineered so as to reduce the incidence of binding by pre-existing antibodies in the bodies of a subject administered such a molecule. Methods for increasing immune response, treating cancer and/or treating an infectious disease with such molecules are provided.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
